Inhibitory circuits in fear memory and fear-related disorders

Front Neural Circuits. 2023 Mar 23:17:1122314. doi: 10.3389/fncir.2023.1122314. eCollection 2023.

Abstract

Fear learning and memory rely on dynamic interactions between the excitatory and inhibitory neuronal populations that make up the prefrontal cortical, amygdala, and hippocampal circuits. Whereas inhibition of excitatory principal cells (PCs) by GABAergic neurons restrains their excitation, inhibition of GABAergic neurons promotes the excitation of PCs through a process called disinhibition. Specifically, GABAergic interneurons that express parvalbumin (PV+) and somatostatin (SOM+) provide inhibition to different subcellular domains of PCs, whereas those that express the vasoactive intestinal polypeptide (VIP+) facilitate disinhibition of PCs by inhibiting PV+ and SOM+ interneurons. Importantly, although the main connectivity motifs and the underlying network functions of PV+, SOM+, and VIP+ interneurons are replicated across cortical and limbic areas, these inhibitory populations play region-specific roles in fear learning and memory. Here, we provide an overview of the fear processing in the amygdala, hippocampus, and prefrontal cortex based on the evidence obtained in human and animal studies. Moreover, focusing on recent findings obtained using genetically defined imaging and intervention strategies, we discuss the population-specific functions of PV+, SOM+, and VIP+ interneurons in fear circuits. Last, we review current insights that integrate the region-specific inhibitory and disinhibitory network patterns into fear memory acquisition and fear-related disorders.

Keywords: GABAergic interneuron; contextual fear conditioning; disinhibition; inhibition; memory; optogenetics.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Fear / physiology
  • GABAergic Neurons / physiology
  • Humans
  • Interneurons* / physiology
  • Learning* / physiology
  • Memory
  • Parvalbumins
  • Vasoactive Intestinal Peptide

Substances

  • Parvalbumins
  • Vasoactive Intestinal Peptide

Grants and funding